These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17873709)

  • 21. The effectiveness of high-dosage amisulpride combined with moderate-dosage sodium valproate treatment for an overweight patient with psychotic bipolar disorder.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E34-5. PubMed ID: 24763785
    [No Abstract]   [Full Text] [Related]  

  • 22. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
    George S; Cowan C
    Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440
    [No Abstract]   [Full Text] [Related]  

  • 24. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 25. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bipolar Disorder in a Young Woman With Preexisting Rapid-Onset Dystonia-Parkinsonism and Successful Treatment With Clozapine and Lithium.
    Mereu A; Serra G; Vicari S; Zanna V
    J Clin Psychopharmacol; 2019; 39(3):277-279. PubMed ID: 30946281
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.
    Englisch S; Enning F; Grosshans M; Marquardt L; Waltereit R; Zink M
    Clin Neuropharmacol; 2010; 33(5):227-9. PubMed ID: 20838213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prolonged QT interval in two cases of amisulpride overdose].
    Barceló B; Yates C; Castanyer B; Puiguriguer J
    Med Clin (Barc); 2010 Apr; 134(12):564-5. PubMed ID: 19376545
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.
    Bowskill SV; Patel MX; Handley SA; Flanagan RJ
    Hum Psychopharmacol; 2012 Sep; 27(5):507-13. PubMed ID: 22996618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
    Amrollahi Z; Rezaei F; Salehi B; Modabbernia AH; Maroufi A; Esfandiari GR; Naderi M; Ghebleh F; Ahmadi-Abhari SA; Sadeghi M; Tabrizi M; Akhondzadeh S
    J Affect Disord; 2011 Mar; 129(1-3):327-31. PubMed ID: 20843556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms.
    Serretti A; Drago A
    Neuropsychobiology; 2010; 62(1):61-71. PubMed ID: 20453536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports.
    Emilien G; Maloteaux JM
    Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of medication adherence in a cohort of patients with bipolar disorder.
    González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
    Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism.
    Riesselman A; Strobl B; Cooley AT; de Leon J
    J Clin Psychopharmacol; 2013 Dec; 33(6):812-4. PubMed ID: 24113673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.